
70
Member Organizations
0
Countries Represented
Stronger
Together for Impact
Evidence
Policy in Action
Infectious Diseases Policy & Advocacy
The Infectious Diseases Policy & Advocacy Committee works at the intersection of evidence, policy, and practice, translating scientific evidence and field realities into effective, equity-driven infectious disease policies.
The Committee brings together civil society, researchers, and policy actors to strengthen political commitment, promote accountable financing, and advance inclusive policy solutions across priority infectious disease areas.
Through strategic advocacy and stakeholder engagement, the Committee aims to connect evidence with decision-making and support policies that respond to the needs of communities and health systems.
Objectives
Evidence-to-Policy Translation
Translate scientific evidence and field realities into actionable, equity-driven infectious disease policy recommendations.
Strategic Advocacy
Shape global and national policy agendas through strategic advocacy and high-level stakeholder engagement.
Political Commitment
Strengthen political commitment to infectious disease response through coordinated civil society advocacy.
Accountable Financing
Promote accountable financing for infectious disease programmes and monitor donor and government commitments.
Inclusive Policy Solutions
Advance inclusive policy solutions that reflect the needs of all communities across priority infectious disease areas.
Civil Society & Research Bridge
Bridge civil society organisations, researchers, and policy actors for coherent, evidence-based advocacy.
Members

Sinisa Skocibusic
Director
IIPH FBH
Priorities
Translate Evidence into Policy
Strengthen Political Commitment
Secure Sustainable Health Financing
Advance Health Equity
Strengthen Civil Society Engagement
Build Global Policy Partnerships
Facts
7.5 million deaths every year
Communicable diseases cause around 7.5 million deaths globally each year. (WHO)
10.7 million people developed TB in 2024
10.7 million people developed TB in 2024; only about 2 in 5 with drug-resistant TB accessed treatment.
41 million people living with HIV
Around 41 million people were living with HIV at the end of 2025. (WHO, 2026)
1 billion influenza cases every year
Seasonal influenza causes around 1 billion cases worldwide each year. (WHO, 2025)
Events

From Bench to Bedside—Together: Patient-Driven Innovation in Infectious Disease Clinical Trials
September 3, 2025 at 2:00:00 AM
Google Meet

From Bench to Bedside—Together: Patient-Driven Innovation in Infectious Disease Clinical Trials
September 3, 2025 at 2:00:00 AM
Google Meet






























































